CLDN1 and prostate carcinoma: In prostate cancer cells, P2X7R was shown to promote invasiveness and metastatic properties and silencing its expression attenuated ATP- or BzATP-induced changes in the expression of EMT-related genes, Snail, E-cadherin and Claudin-1 [15].